New technique could boost corneal transplant acceptance rates
New research from the University of Texas Southwestern Medical Center at Dallas has detailed a new technique that may be able to boost patients' acceptance rates of corneal transplants. This is according to a study published in the American Journal of Transplantation.A corneal transplant, also referred to as a corneal graft, is an operation involving the removal of all or part of a damaged cornea. Using healthy corneal tissue from a suitable donor, the damaged cornea is replaced. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - January 3, 2014 Category: Consumer Health News Tags: Eye Health / Blindness Source Type: news
Study identifies potential new strategy to improve odds of corneal transplant acceptance
For the estimated 10 percent of patients whose bodies reject a corneal transplant, the odds of a second transplant succeeding are poor. All that could change, however, based on a UT Southwestern Medical Center study that has found a way to boost the corne (Source: UT Southwestern Medical Center News)
Source: UT Southwestern Medical Center News - December 31, 2013 Category: Hospital Management Source Type: news
Study identifies potential new strategy to improve odds of corneal transplant acceptance
(UT Southwestern Medical Center) For the estimated 10 percent of patients whose bodies reject a corneal transplant, the odds of a second transplant succeeding are poor. All that could change, however, based on a UT Southwestern Medical Center study that has found a way to boost the corneal transplant acceptance rate. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 30, 2013 Category: Global & Universal Source Type: news
DMEK Techniques Enhanced for Corneal TransplantDMEK Techniques Enhanced for Corneal Transplant
Surgeons are refining Descemet membrane endothelial keratoplasty (DMEK) to improve corneal transplant outcomes and make the procedure easier to perform. Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 27, 2013 Category: Consumer Health News Tags: Ophthalmology News Source Type: news
NIH-funded study finds donor age not a factor in most corneal transplants
Ten years after a transplant, a cornea from a 71-year-old donor is likely to remain as healthy as a cornea from a donor half that age, according to a study funded by the National Institutes of Health. Corneas from donors over age 71 perform slightly less well, but still remain healthy for the majority of transplant recipients after 10 years, the study found. (Source: News from NEI)
Source: News from NEI - November 15, 2013 Category: Opthalmology Source Type: news
NIH-funded study finds donor age not a factor in most corneal transplants
(NIH/National Eye Institute) Ten years after a transplant, a cornea from a 71-year-old donor is likely to remain as healthy as a cornea from a donor half that age, according to a study funded by the National Institutes of Health. Corneas from donors over age 71 perform slightly less well, but still remain healthy for the majority of transplant recipients after 10 years, the study found. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 15, 2013 Category: Global & Universal Source Type: news
Soccer Fans Put Their Hearts Into Organ Donor CampaignSoccer Fans Put Their Hearts Into Organ Donor Campaign
Not even death can sever fans' links with their beloved soccer team, promises a campaign to boost organ donations in Brazil which has helped to cut waiting lists for cornea and heart transplants to all-time lows. Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 22, 2013 Category: Consumer Health News Tags: Transplantation News Source Type: news
Topical formulation identified for prolonged graft survival in corneal transplants
Argos Therapeutics Inc., a biopharmaceutical company focused on the development and commercialization of therapies that modulate the immune system to treat cancer, infectious diseases, transplant rejection, autoimmune and inflammatory diseases, has announced the publication of key findings on its soluble recombinant human CD83 protein (sCD83) in cornea transplants. The study, conducted in rodents, demonstrates that CD83 can modulate the immune system and promote graft survival... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - August 20, 2013 Category: Consumer Health News Tags: Transplants / Organ Donations Source Type: news
Successful Corneal Transplant With Pre-Loaded Donor Tissue: A First For Massachusetts Eye And Ear
The first successful cornea transplant with donor endothelial tissue preloaded by an eye bank has been performed at Massachusetts Eye and Ear in Boston, Mass. Roberto Pineda II, M.D., Director of the Refractive Surgery Service at Mass. Eye and Ear, and an Associate Professor of Ophthalmology at Harvard Medical School, recently performed the groundbreaking transplant. Dr. Pineda performed the surgery utilizing donor endothelial tissue that was prepared and pre-loaded into EndoGlide™ (Angiotech Pharmaceuticals, Inc... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - May 10, 2013 Category: Consumer Health News Tags: Eye Health / Blindness Source Type: news
First corneal transplant with pre-loaded donor tissue performed at Mass. Eye and Ear
(Massachusetts Eye and Ear Infirmary) The first successful cornea transplant with donor endothelial tissue preloaded by an eye bank has been performed at Massachusetts Eye and Ear in Boston, Mass. Roberto Pineda II, M.D., Director of the Refractive Surgery Service at Mass. Eye and Ear, and an associate professor of ophthalmology at Harvard Medical School, recently performed the groundbreaking transplant. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 7, 2013 Category: Global & Universal Source Type: news
